JNK and p53 stress signaling cascades are altered in MCF-7 cells resistant to tumor necrosis factor-mediated apoptosis

Journal of Interferon and Cytokine Research

Volumn 19, Issue 3, 1999, Pages 261-269

  Doman, Raymond K ^a   Perez, Margot ^a   Donato, Nicholas J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; NUCLEAR PROTEIN; PROTEIN BAX; PROTEIN P53; RECOMBINANT TUMOR NECROSIS FACTOR; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS;

EID: 0032918249     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099314199     Document Type: Article

References (51)

1. HETTS, S.W. (1998). To die or not to die: an overview of apoptosis and its role in disease. JAMA 279, 300-307.
2. NAGATA, S., and GOLSTEIN, P. (1995). The Fas death factor. Science 267, 1449-1456.
3. CLEVELAND, J.L., and IHLE, J.N. (1995). Contenders in FasL/TNF death signaling. Cell 81, 479-482.
4. HSU, H., XIONG, J., and GOEDDEL, D.V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81, 495-504.
5. BOLDIN, M.P., GONCHAROV, T.M., GOLTSEV, Y.V., and WALLACH, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease in FAS/APO-1- and TNF receptor-induced cell death. Cell 85, 213-222.
6. MUZIO, M., CHINNAIYAN, A.M., KISCHKEL, F.C., O'ROURKE, K., SCHEVCHENKO, A., NI, J., SCAFFIDI, C., BRJETZ, J.D., ZHANG, M., GENTZ, R., MANN, M., KRAMMER, P.M., PETER, M.E., and DIXIT, V.M. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827.
7. LUI, Z.G., BASKARAN, R., LEA-CHOU, E.T., WOOD, L.D., CHEN, Y., KARIN, M., and WANG, J.Y. (1996). Three distinct signaling responses by murine fibroblasts to genotoxic stress. Nature 384, 273-276.
8. SUGARMAN, B.J., AGGARWAL, B.B., HASS, P.E., FLIGARI, I.S., PALLADINO, M.A., and SHEPARD, H.M. (1985). Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230, 943-945.
9. PFIZENMAIER, K., KRONKE, M., SCHEURICH, P., and NAGEL, G.A. (1987). Tumor necrosis factor-alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition. Blut 55, 1-10.
10. 2 in NK-kappa B activation by either cytokine in both primary and transformed endothelial cells. J. Biol. Chem. 272, 25941-25950.
11. SHOJT, Y., UEDONO, Y., ISHIKURA, H., TAKEYAMA. N., and TANAKA, T. (1995). DNA damage induced by tumor necrosis factor-alpha in L929 cells is mediated by mitochondrial oxygen radical formation. Immunology 84, 543-548.
12. ADAM, D., WIEGMAN, K., ADAM-KLAGES, S., RUFF, A., and KRONKE, M. (1996). A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J. Biol. Chem. 271, 14617-14622.
13. MORIGUCHI, T., TOYOSHIMA, F., MASUYAMA, N., HANAFUSA, H., GOTOH, Y., and NISHIDA, E. (1997). A novel SAPK/JNK kinase, MKK7, stimulated by TNF alpha and cellular stress. EMBO J. 16, 7045-7053.
14. REINHARD, C., SHAMOON, B., SHYAMALA, V., and WILLIAMS, L. (1997). Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J. 16, 1080-1092.
15. SLUSS, H.K., BARRETT, T., DERIJARD, B., and DA VIS, R.J. (1994). Signal transduction by tumor necrosis factor mediated by JNK protein kinascs. Mol. Cell. Biol. 14, 8376-8384.
16. DONATO, N.J., and PEREZ, M. (1998). Tumor necrosis factor-induced apoptosis stimulates p53 accumulation and p21 WAF1 proteolysis in ME-180 cells. J. Biol. Chem. 273, 5067-5072.
17. JEOUNG, D., TANG, B., and SONENBERG, M. (1995). Effects of tumor necrosis factor-alpha on anti-mitogenicity and cell cycle-regulated proteins in MCF-7 cell. J. Biol. Chem. 270, 18367-18373.
18. KLEFSTROM, J., ARIGHI, E., LITTLEWOOD, T., JAATTELA, M., SAKSELA, E., EVANS, G.I., and ALITALO, K. (1997). Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappa B activation. EMBO J. 16, 7382-7492.
19. HAINAUT, P. (1995). The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr. Opin. Oncol. 7, 76-82.
20. LOWE, S.W., RULEY, H.E., JACKS, T., and HOUSMAN, D.E. (1993). p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967.
21. DONATO, N.J., YAN, D.H., HUNG, M.-C., and ROSENBLUM, M.G. (1993). Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells. Cell Growth Differ. 4, 411-419.
22. SCHREIBER, E., MATHIAS, P., MULLER, M.M., and SCHAFFNER, W. (1989). Rapid detection of octamer binding proteins with "mini-extracts." Nucleic Acids Res. 17, 6419.
23. NABEL, G., and BALTIMORE, D. (1987). An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711-713.
24. NICHOLSON, D.W., ALI, A., THORNBERRY, N.A., VAILLANCOURT, J.P., DING, C.K., GALLANT. M., GAREAU, Y., GRIFFIN. P.R., LABELLE. M., LAZENBNIK, Y.A., et al. (1995). Identification and inhibition of the ICE/CED3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
25. HUMKE. E.W., NI, J., and DIXIT. V.M. (1998). ERICE a novel FLICE-activated caspase. J. Biol. Chem. 273, 15702-15707.
26. THORNBERRY, N.A., PETERSON. E.P., ZHAO, J.J., HOWARD, A.D., GRIFFIN, P.R., and CHAPMAN, K.T. (1994). Inactivation of interleukin-l beta converting enzyme by peptide (acyloxy)methyl ketones. Biochemistry 33, 3934-3940.
27. MARELLI, M., CUNNINGHAM, G.R., HAIDACHER, S.J., PADAYATTY, S.J., STURGIS, L., KAGAN, C., and DENNER, L. (1998). Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res. 58, 76-83.
28. CAI, Z., BETTAIED, A., MAHDANI, M.E., LEGRES, L., STANCOU, R., MASLIAH, J., and CHOUAIB, S. (1997). Alteration in the sphingomyelin-ceramide pathway is associated with resistance of human breast carcinoma MCF-7 cells to tumor necrosis factor-alpha-mediated cytotoxicity. J. Biol. Chem. 272, 6918-6926.
29. GALCHEVA-GARGOVA, Z., DERIJARD, B., WU, I.H., and DAVIS, R.J. (1994). An osmosensing signal transduction pathway in mammalian cells. Science 265, 806-808.
30. CHEN, Y.R., MEYERS, C.F., and TAN, T.H. (1996). Persistent activation of c-Jun N-terminal kinase 1 in gamma radiation-induced apoptosis. J. Biol. Chem. 271, 631-634.
31. CHEN, Y.R., WANG, X., TEMPLETON, D., and TAN, T.H. (1996). The role of c-Jun N-terminal kinase in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271, 31929-31936.
32. GUO, Y.-L., BAYSAL, K., KANG, B., YANG, L.-J., and WILLIAMSON, J.R. (1998). Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J. Biol. Chem. 273, 4027-4034.
33. FAN, S., SMITH, M.L., RIVETT, L.L., D.J., DUBA, D., ZHAN, Q., KOHN, K.W., FORNACE, A.J., Jr., and O'CONNOR, P.M. (1995). Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxyfylline. Cancer Res. 55, 1649-1654.
34. 1 arrest. Cell 76, 1013-1023.
35. EL-DEIRY, W.S., TOKINO, T., VELCULESCU, V.E., LEU, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, W.E., KINZLER, K.W., and VOGELSTEIN, B. (1993). WAF1, a potential mediator of p53 suppression. Cell 75, 817-825.
36. LO, Y.Y.C., WONG, J.M.S., and CRUZ, T.F. (1996). Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J. Biol. Chem. 271, 15703-15707.
37. OSBORN, M.T., and CHAMBERS, T.C. (1996). Role of stress-activated/c-Jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs. J. Biol. Chem. 271, 30950-30955.
38. SANCHEZ-PEREZ, I., MURGUIA, J.R., and PERONA, R. (1998). Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene 16, 533-540.
39. SRINIVASAN, A., LI, F., KODANDAPANI, L., SMIDT, R., Jr., KREBS, J.F., FRITZ, L.C., WU, J.C., and TOMASELLI, K.J. (1998). BcI-xL functions downstream of caspase 8 to inhibit Fasand tumor necrosis factor receptor 1-induced apoptosis of MCF-7 breast carcinoma cells. J. Biol. Chem. 273, 4523-4529.
40. CAI, Z., CAPOULADE, C., MOYRET-LALLE, C., AMORGUERET, M., FEUNTEUN, J., LARSEN, A.K., PAILLERETS, B.B., and CHOUAIB, S.I.B. (1997). Resistance of MCF-7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Oncogene 15, 2817-2826.
41. DBAIBO, G.S., OBEID, L.M., and HANNUN, Y.A. (1993). Tumor necrosis factor-alpha signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of NF-kappa B. J. Biol. Chem. 268, 17762-17766.
42. 2 in breast carcinoma cells. Oncogene 10, 2297-2305.
43. MIYASHITA, T., and REED, J.C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
44. CHANG, Y.C., LEE, Y.S., TEJIMA, T., TANAKA, K., OMURA, S., HEINTZ, N.H., MITSUI, Y., and MAGAE, J. (1998). mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway. Cell Growth Differ. 9, 79-84.
45. OGRETMAN, B., and SAFA, A.R. (1997). Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells. Oncogene 14, 499-506.
46. YIN, D., KONDO, S., BARNETT, G.H., MORIMURA, T., and TAKEUCHI, J. (1995). Tumor necrosis factor-alpha induces p53-dependent apoptosis in rat glioma cells. Neurosurgery 27, 762-765.
47. MEIER, B., RADEKE, H.H., SELLE, S., YOUNES, M., SIES, H., RESCH, K., and HABERMEHL, G.G. (1989). Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-alpha. Biochem. J. 263, 539-545.
48. FLOHE, L., BRIGELIUS-FLOHE, R., SALIOU, C., TRABER, M.G., and PACKER, L. (1997). Redox regulation of NF-kappa B activation. Free Radical Biol. Med. 22, 1115-1126.
49. WONG, G.H.W., ELWELL, J.H., OBERLY, L.W., and GOEDDEL, D.V. (1989). Manganous Superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58, 923-931.
50. IP, Y.T., and DAVIS, R.J. (1998). Signal transduction by the c-Jun N-terminal kinase - from inflammation to development. Curr. Opin. Cell Biol. 10, 205-219.
51. COHEN, P. (1996). Dissection of the protein kinase cascades that mediate cellular response to cytokines and cellular stress. Adv. Pharmacol. 36, 15-27.